ArticlebioRxiv : the preprint server for biology2025
Single cell and spatial characterization of the human pancreas reveals drivers of beta cell dysfunction in cystic fibrosis.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Cystic fibrosis (CF) causes severely damaged pancreas morphology and results in high rates of cystic fibrosis-related diabetes (CFRD), but the cellular pathways and regulatory programs driving CFRD pathogenesis in the pancreas are not understood. In this study, we performed single cell multiomic and spatial profiling of 2.04M cells in the pancreas from 23 non-disease and CF donors and defined regulatory programs and tissue niches of specific cell types and sub-types in CF. A high-mucin sub-type of ductal cells had relatively preserved abundance, altered localization and up-regulated stress, secretion and pro-fibrotic activity in CF, and conventional ductal cells showed evidence for transition to the high-mucin state. Increased inflammatory and fibrotic pathway activity in CF was linked to closer proximity and crosstalk between immune and stellate cells in specific niches. Beta cells had extensive genomic changes in CF, including increased stress and insulin secretion-related processes, and these changes were broadly distinct from those in type 1 and type 2 diabetes. Islets in CF preferentially localized near large adipose tissue and collagen structures, and both areas were strongly linked to beta cell loss in CF due to signaling from adipocytes, macrophages, stellate, and high-mucin ductal cells. Overall, our results reveal cellular drivers of pancreatic dysfunction in CF and offer new in-roads to preserving beta cells in CFRD.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.